keyword
https://read.qxmd.com/read/38807947/soluble-suppression-of-tumorigenicity-2-associated-with-major-adverse-cardiac-events-in-children-with-myocarditis
#1
JOURNAL ARTICLE
Tongtong Shi, Jing Ge, Shan Li, Yali Zhang
OBJECTIVE: Soluble suppression of tumorigenicity 2 (sST2) is associated with the prognosis of some cardiac diseases, but studies on sST2 and the prognosis of patients with myocarditis are rare. This study investigated the relationship between major adverse cardiovascular events (MACEs) and sST2 during hospitalization in pediatric patients with myocarditis. METHODS: This was a single-center retrospective cohort study. A total of 252 patients aged ≤14 years diagnosed with myocarditis were enrolled...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38806090/tackling-the-challenges-of-human-chagas-disease-a-comprehensive-review-of-treatment-strategies-in-the-chronic-phase-and-emerging-therapeutic-approaches
#2
REVIEW
Laís Gomes Ramos, Kátia Regina de Souza, Policarpo Ademar Sales Júnior, Camila Capelini Câmara, Frederico S Castelo-Branco, Nubia Boechat, Samir Aquino Carvalho
Chagas disease (CD), caused by the flagellated protozoan Trypanosoma cruzi (T. cruzi), affects approximately 7 million people worldwide and is endemic in Latin America, especially among socioeconomically disadvantaged populations. Since the 1960s, only two drugs have been commercially available for treating this illness: nifurtimox (NFX) and benznidazole (BZN). Although these drugs are effective in the acute phase (AP) of the disease, in which parasitemia is usually high, their cure rates in the chronic phase (CP) are low and often associated with several side effects...
May 26, 2024: Acta Tropica
https://read.qxmd.com/read/38798448/post-acute-cardiovascular-outcomes-of-covid-19-in-children-and-adolescents-an-ehr-cohort-study-from-the-recover-project
#3
Bingyu Zhang, Deepika Thacker, Ting Zhou, Dazheng Zhang, Yuqing Lei, Jiajie Chen, Elizabeth Chrischilles, Dimitri A Christakis, Soledad Fernandez, Vidu Garg, Susan Kim, Abu S M Mosa, Marion R Sills, Bradley W Taylor, David A Williams, Qiong Wu, Christopher B Forrest, Yong Chen
BACKGROUND: The risk of cardiovascular outcomes in the post-acute phase of SARS-CoV-2 infection has been quantified among adults and children. This paper aimed to assess a multitude of cardiac signs, symptoms, and conditions, as well as focused on patients with and without congenital heart defects (CHDs), to provide a more comprehensive assessment of the post-acute cardiovascular outcomes among children and adolescents after COVID-19. METHODS: This retrospective cohort study used data from the RECOVER consortium comprising 19 US children's hospitals and health institutions between March 2020 and September 2023...
May 15, 2024: medRxiv
https://read.qxmd.com/read/38790576/congenital-long-qt-syndrome-in-children-and-adolescents-a-general-overview
#4
REVIEW
Elia Balestra, Marco Bobbo, Marco Cittar, Daniela Chicco, Biancamaria D'Agata Mottolese, Egidio Barbi, Thomas Caiffa
Congenital long QT syndrome (LQTS) represents a disorder of myocardial repolarization characterized by a prolongation of QTc interval on ECG, which can degenerate into fast polymorphic ventricular arrhythmias. The typical symptoms of LQTS are syncope and palpitations, mainly triggered by adrenergic stimuli, but it can also manifest with cardiac arrest. At least 17 genotypes have been associated with LQTS, with a specific genotype-phenotype relationship described for the three most common subtypes (LQTS1, -2, and -3)...
May 11, 2024: Children
https://read.qxmd.com/read/38784686/fatal-arrhythmic-complications-of-multisystemic-inflammatory-syndrome-mis-c-in-a-pediatric-patient
#5
Chika C Oragui, Arthur Dilibe
In 2019, the emergence of the coronavirus disease 2019 (COVID-19) virus triggered a global pandemic, reminiscent of the magnitude witnessed during the flu pandemic of 1918. Initially, children often presented with either asymptomatic or mild upper respiratory tract infection symptoms. However, in the post-acute phase, a distinct syndrome affecting multiple organ systems emerged, sharing similarities with Kawasaki's disease. This syndrome was later classified as multisystem inflammatory syndrome in children (MIS-C) by the Pediatric Intensive Care Society in April 2020...
May 2024: Curēus
https://read.qxmd.com/read/38780650/congenital-central-hypoventilation-syndrome-in-korea-20%C3%A2-years-of-clinical-observation-and-evaluation-of-the-ventilation-strategy-in-a-single-center
#6
JOURNAL ARTICLE
Min Jeong Lee, Ji Soo Park, Kyunghoon Kim, Jung Min Ko, June Dong Park, Dong In Suh
Congenital central hypoventilation syndrome (CCHS) is a rare genetic disorder characterized by hypoventilation due to impaired breathing control by the central nervous system and other symptoms of autonomic dysfunction. Mutations in paired-like homeobox 2 B (PHOX2B) are responsible for most cases of CCHS. Patients with CCHS have various phenotypes and severities, making the diagnosis difficult. This study aimed to present a comprehensive single-center experience of patients with CCHS, including key clinical features, treatment strategies, and outcomes...
May 23, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38766606/wideband-magnetic-resonance-sequencing-to-decrease-image-artifact-in-a-child-with-a-cardiac-implantable-device
#7
Lajja Desai, Andrada Popescu, Laleh Golestanirad, Gregory Webster, Daniel Kim
No abstract text is available yet for this article.
April 2024: HeartRhythm Case Reports
https://read.qxmd.com/read/38749643/pediatric-and-familial-genetic-arrhythmia-syndromes-scn5a-related-disorders-when-it-is-not-long-qt-type-3-clinical-signs-and-symptoms
#8
REVIEW
Stephanie F Chandler, Gregory Webster, Christina Y Miyake
The following case series presents three different pediatric patients with SCN5A-related disease. In addition, family members are presented to demonstrate the variable penetrance that is commonly seen. Identifying features of this disease is important, because even in the very young, SCN5A disorders can cause lethal arrhythmias and sudden death.
June 2024: Cardiac Electrophysiology Clinics
https://read.qxmd.com/read/38749642/pediatric-and-familial-genetic-arrhythmia-syndromes-evaluation-of-bidirectional-ventricular-tachycardia-differential-diagnosis
#9
REVIEW
Mohammad A Ebrahim, Tam Dan Pham, Mary C Niu, Susan P Etheridge, Martin Tristani-Firouzi, Christina Y Miyake
Bidirectional ventricular tachycardia is a unique arrhythmia that can herald lethal arrhythmia syndromes. Using cases based on real patient stories, this article examines 3 different presentations to help clinicians learn the differential diagnosis associated with this condition. Each associated genetic disorder will be briefly discussed, and valuable tips for distinguishing them from each other will be provided.
June 2024: Cardiac Electrophysiology Clinics
https://read.qxmd.com/read/38749641/pediatric-and-familial-genetic-arrhythmia-syndromes-evaluation-of-prolonged-qtc-differential-diagnosis-and-what-you-need-to-know
#10
REVIEW
Mary C Niu, Susan P Etheridge, Martin Tristani-Firouzi, Christina Y Miyake
The case series reviews differential diagnosis of a genetic arrhythmia syndrome when evaluating a patient with prolonged QTc. Making the correct diagnosis requires: detailed patient history, family history, and careful review of the electrocardiogram (ECG). Signs and symptoms and ECG characteristics can often help clinicians make the diagnosis before genetic testing results return. These skills can help clinicians make an accurate and timely diagnosis and prevent life-threatening events.
June 2024: Cardiac Electrophysiology Clinics
https://read.qxmd.com/read/38742589/evaluation-of-t-wave-memory-after-accessory-pathway-ablation-in-pediatric-patients-with-wolff-parkinson-white-syndrome
#11
JOURNAL ARTICLE
Ensar Duras, Ayse Sulu, Hasan Candas Kafali, Sezen Gulumser Sisko, Bahar Caran, Yakup Ergul
BACKGROUND: T-wave memory (TWM) is a rare cause of T-wave inversion (TWI). Alterations in ventricular activation due to abnormal depolarization may cause repolarization abnormalities on the ECG, even if myocardial conduction returns to normal. These repolarization changes are defined as TWM. In our study, we aimed to determine the frequency of TWM development and the predictors affecting it in the pediatric population who underwent accessory pathway (AP) ablation due to Wolff-Parkinson-White (WPW) syndrome...
May 14, 2024: Pacing and Clinical Electrophysiology: PACE
https://read.qxmd.com/read/38726927/definition-risk-factors-and-outcome-analysis-of-prolonged-mechanical-ventilation-in-children
#12
JOURNAL ARTICLE
Ruonan Chen, Yanling Liu, Hongxing Dang
OBJECTIVE: This study aims to explore the time threshold for defining prolonged mechanical ventilation (PMV) in children, along with its risk factors and outcomes. METHODS: A prospective cohort study was conducted on children aged 29 days-18 years, who were consecutively admitted to two Pediatric Intensive Care Units (PICUs) at Children's Hospital of Chongqing Medical University, from October 2020 to June 2021. The study included patients receiving mechanical ventilation (MV) for more than 2 days (each day >6 h)...
May 10, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38724761/machine-learning-to-predict-outcomes-of-fetal-cardiac-disease-a-pilot-study
#13
JOURNAL ARTICLE
L E Nield, C Manlhiot, K Magor, L Freud, B Chinni, A Ims, N Melamed, O Nevo, T Van Mieghem, D Weisz, S Ronzoni
Prediction of outcomes following a prenatal diagnosis of congenital heart disease (CHD) is challenging. Machine learning (ML) algorithms may be used to reduce clinical uncertainty and improve prognostic accuracy. We performed a pilot study to train ML algorithms to predict postnatal outcomes based on clinical data. Specific objectives were to predict (1) in utero or neonatal death, (2) high-acuity neonatal care and (3) favorable outcomes. We included all fetuses with cardiac disease at Sunnybrook Health Sciences Centre, Toronto, Canada, from 2012 to 2021...
May 9, 2024: Pediatric Cardiology
https://read.qxmd.com/read/38721668/molecular-autopsy-with-banked-cord-blood-reveals-brugada-syndrome-in-past-sudden-death-case
#14
JOURNAL ARTICLE
Eitaro Kume, Masaru Yamakawa, Chisato Miyakoshi, Chie Aota, Satoru Tsuruta, Minoru Horie, Seiko Ohno
Molecular autopsy has recently been gaining attention as a means of postmortem diagnosis; however, it is usually performed using the victim's blood sample at the time of death. Here, we report the first case of a deceased infant with Brugada syndrome whose diagnosis was made with banked cord blood. A seemingly healthy 1-year-old male infant collapsed while having a fever; this collapse was witnessed by his mother. Despite cardiopulmonary resuscitation, he died of ventricular fibrillation. No abnormalities of cardiac structure were identified on autopsy...
May 9, 2024: Pediatrics
https://read.qxmd.com/read/38713124/a-prospective-multicenter-feasibility-study-of-a-miniaturized-implantable-continuous-flow-ventricular-assist-device-in-smaller-children-with-heart-failure
#15
JOURNAL ARTICLE
Christopher S Almond, Ryan Davies, Iki Adachi, Marc Richmond, Sabrina Law, Hari Tunuguntla, Chad Mao, Fawwaz Shaw, Jodie Lantz, Peter D Wearden, Lori C Jordan, Rebecca N Ichord, Kristin Burns, Victor Zak, Ashley Magnavita, Selena Gonzales, Jennifer Conway, Aamir Jeewa, D 'Andrea Freemon, Mario Stylianou, Lynn Sleeper, John C Dykes, Michael Ma, Francis Fynn-Thompson, Angela Lorts, David Morales, Christina Vanderpluym, Kurt Dasse, M Patricia Massicotte, Robert Jaquiss, William T Mahle
BACKGROUND: There is no FDA-approved left ventricular assist device (LVAD) for smaller children permitting routine hospital discharge. Smaller children supported with LVADs typically remain hospitalized for months awaiting heart transplant-a major burden for families and a challenge for hospitals. We describe the initial outcomes of the Jarvik 2015, a miniaturized implantable continuous flow LVAD, in the NHLBI-funded Pumps for Kids, Infants, and Neonates (PumpKIN) study, for bridge-to-heart transplant...
April 30, 2024: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38709259/risk-factors-and-survival-outcomes-in-children-with-early-cardiotoxicity-after-allogeneic-hematopoietic-stem-cell-transplantation
#16
JOURNAL ARTICLE
Ke Tong, Yan Meng, Luying Zhang, Xiaoying Lei, Qihui Liu, Xianmin Guan, Jie Yu, Ying Dou
Cardiotoxicity in children is a potentially fatal complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT); therefore, early identification of risk factors can improve patient prognosis. However, there are few data on the clinical characteristics of early-stage cardiotoxicity in children after allo-HSCT. We conducted a retrospective single-center study of pediatric patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) between January 2016 and December 2022 at the Children's Hospital Affiliated with Chongqing Medical University to evaluate the clinical characteristics of early cardiac events (ECEs) after allo-HSCT and their impact on survival outcomes...
May 6, 2024: Annals of Hematology
https://read.qxmd.com/read/38702753/cardiovascular-involvement-in-children-with-covid-19-temporally-related-multisystem-inflammatory-syndrome-mis-c-can-cardiac-magnetic-resonance-arrive-to-the-heart-of-the-problem
#17
JOURNAL ARTICLE
Maria Cristina Maggio, Alessio Lembo, Francesca Finazzo, Annalisa Alaimo, Guglielmo Francesco Benfratello, Giovanni Corsello
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) shows a significant overlap of symptoms with other hyper-inflammatory diseases such as Kawasaki disease (KD), but the real difference of the two conditions is still matter of debate. Coronary artery lesions (CAL) are the most relevant complication in KD. Nonetheless, CAL, myocarditis, pericarditis, arrhythmia are the main cardiovascular complications in MIS-C. A close clinical assessment is mandatory, both at the diagnosis and during the follow-up, by ECG and echocardiography...
May 3, 2024: Italian Journal of Pediatrics
https://read.qxmd.com/read/38687993/-surgical-strategies-in-ebstein-anomaly-28-years-experience-in-a-pediatric-hospital
#18
JOURNAL ARTICLE
Mariela Mouratian, Claudia Villalba, Agustina Ramos, Fernando Diez-Mori, Lafuente M Victoria, Erica Stelmaszewski, Carla Pasinato, Juliana Medina, Marisa Di Santo, Pablo García-Delucis
OBJECTIVES: Ebstein anomaly is a congenital defect characterized by a lack of delamination and apical displacement of the tricuspid valve, tricuspid insufficiency, right atrial enlargement, and ventricular dysfunction. To analyze the results and evolution of the different surgical strategies, data were collected from 45 patients operated on during 1990-2018. Twenty-six patients were included with a median age at initial surgery of 11.3 years (range: 13 days-18.6 years). METHOD: Procedures were plastic 10 patients (38%), cone technique reconstruction 11 (42%), and replacement 5 (19%)...
April 30, 2024: Archivos de Cardiología de México
https://read.qxmd.com/read/38684446/electrophysiological-phenotyping-of-left-ventricular-noncompaction-cardiomyopathy-in-pediatric-populations-a-systematic-review
#19
JOURNAL ARTICLE
Lindsey A Fitzsimons, Delanie M Kneeland-Barber, Gracie C Hannigan, David A Karpe, Lyman Wu, Michael Colon, Jess Randall, Kerry L Tucker
Left ventricular noncompaction cardiomyopathy (LVNC) is a structural heart defect that has been associated with generation of arrhythmias in the population and is a cause of sudden cardiac death with severe systolic dysfunction and fatal arrhythmias. LVNC has gained increasing acknowledgment with increased prevalence. We conducted a systematic review of reported electrocardiogram (ECG) results for pediatric LVNC patients. EMBASE database query was performed, yielding 4531 articles related to LVNC between 1990 and December 2023...
May 2024: Physiological Reports
https://read.qxmd.com/read/38675178/an-overview-of-the-pharmacokinetics-and-pharmacodynamics-of-landiolol-an-ultra-short-acting-%C3%AE-1-selective-antagonist-in-atrial-fibrillation
#20
REVIEW
Mariana Floria, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi, Celina Silvia Stafie, Magdalena Cuciureanu, Viorel Scripcariu, Daniela Maria Tanase
Landiolol is an ultra-short-acting, selective β1-adrenergic receptor blocker that was originally approved in Japan for the treatment of intraoperative tachyarrhythmias. It has gained attention for its use in the management of tachyarrhythmias and perioperative tachycardia, especially atrial fibrillation for both cardiac and non-cardiac surgeries. It can be the ideal agent for heart rate control due to its high β1-selectivity, potent negative chronotropic effect, a limited negative inotropic potential, and an ultrashort elimination half-life (around 4 min); moreover, it may have a potential therapeutic effects for sepsis and pediatric patients...
April 8, 2024: Pharmaceutics
keyword
keyword
21586
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.